nach oben

Intensive Care Medicine

Erschienen in:

02.06.2018 | Editorial

Angiotensin inhibition in patients with acute kidney injury: Dr. Jekyll or Mr. Hyde?

verfasst von: Michael Joannidis, Eric Hoste

Erschienen in: Intensive Care Medicine | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Excerpt

Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are among the most frequently applied antihypertensive drugs. Their beneficial pleiotropic effects go far beyond blood pressure reduction. Remodeling of myocardium enhances the effects of afterload reduction for the heart and makes ACEIs/ARBs a key drug in treatment of chronic heart failure as well as for secondary prevention after acute myocardial infarction. With regard to the kidney, ACEIs/ARBs have demonstrated to reduce proteinuria and slow progression of CKD [1]. …

KDIGO, Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2012) Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013:1–150

Norman JT, Stidwill R, Singer M, Fine LG (2003) Angiotensin II blockade augments renal cortical microvascular pO₂ indicating a novel, potentially renoprotective action. Nephron Physiol 94:39–46CrossRef

Tiefenbacher CP, Friedrich S, Bleeke T, Vahl C, Chen X, Niroomand F (2004) ACE inhibitors and statins acutely improve endothelial dysfunction of human coronary arterioles. Am J Physiol Heart Circ Physiol 286:H1425–H1432CrossRefPubMed

Sprenger-Mahr H, Zitt E, Lhotta K (2016) Acute kidney injury treated with dialysis outside the intensive care unit: a retrospective observational single-center study. PLoS ONE 11:e0163512CrossRefPubMedPubMedCentral

Tomlinson LA, Abel GA, Chaudhry AN, Tomson CR, Wilkinson IB, Roland MO, Payne RA (2013) ACE inhibitor and angiotensin receptor-II antagonist prescribing and hospital admissions with acute kidney injury: a longitudinal ecological study. PLoS ONE 8:e78465CrossRefPubMedPubMedCentral

Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, Zarbock A (2017) Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med 43:1551–1561CrossRefPubMedPubMedCentral

Joannidis M, Druml W, Forni LG, Groeneveld ABJ, Honore PM, Hoste E, Ostermann M, Oudemans-van Straaten HM, Schetz M (2017) Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017: expert opinion of the working group on prevention, AKI section, European society of intensive care medicine. Intensive Care Med 43:730–749CrossRefPubMedPubMedCentral

KDIGO (2012) Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1–138CrossRef

Ryckwaert F, Colson P, Ribstein J, Boccara G, Guillon G (2001) Haemodynamic and renal effects of intravenous enalaprilat during coronary artery bypass graft surgery in patients with ischaemic heart dysfunction. Br J Anaesth 86:169–175CrossRefPubMed

10.

Wagner F, Yeter R, Bisson S, Siniawski H, Hetzer R (2003) Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction. Crit Care Med 31:1421–1428CrossRefPubMed

11.

Gayat E, Hollinger A, Cariou A, Deye N, Vieillard-Baron A, Jaber S, Chousterman BJ, Lu Q, Monnet X, Leone M, Guidet B, Sonneville R, Lefrant JY, Fournier M-C, Resche-Rigon M, Mebazaa A, Legrand M (2018) Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury. Intensive Care Med. https://doi.org/10.1007/s00134-018-5160-6 CrossRefPubMed

12.

Forni LG, Darmon M, Ostermann M, Oudemans-van Straaten HM, Pettila V, Prowle JR, Schetz M, Joannidis M (2017) Renal recovery after acute kidney injury. Intensive Care Med 43:855–866CrossRefPubMedPubMedCentral

13.

Klein SJ, Brandtner AK, Peball M, Joannidis M (2017) Life after acute kidney injury: long-term consequences and implications for clinical practice. Med Klinik Intensivmed Notf 112:597–604CrossRef

14.

Gammelager H, Christiansen CF, Johansen MB, Tonnesen E, Jespersen B, Sorensen HT (2014) Three-year risk of cardiovascular disease among intensive care patients with acute kidney injury: a population-based cohort study. Crit Care 18:492CrossRefPubMedPubMedCentral

15.

Chawla LS, Amdur RL, Shaw AD, Faselis C, Palant CE, Kimmel PL (2014) Association between AKI and long-term renal and cardiovascular outcomes in United States veterans. Clin J Am Soc Nephrol 9:448–456CrossRefPubMed

Titel: Angiotensin inhibition in patients with acute kidney injury: Dr. Jekyll or Mr. Hyde?
verfasst von: Michael Joannidis
Eric Hoste
Publikationsdatum: 02.06.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Intensive Care Medicine / Ausgabe 7/2018
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-018-5223-8

Neu im Fachgebiet AINS

23.04.2024 | Appendizitis | Nachrichten

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Angiotensin inhibition in patients with acute kidney injury: Dr. Jekyll or Mr. Hyde?

Excerpt

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Update AINS

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2018

Is there a disconnect between what we do and what we should do? A survey of intensive care physicians and nurses in California

The dark sides of fluid administration in the critically ill patient

Relative risk and population-attributable fraction of ICU death caused by susceptible and resistant Pseudomonas aeruginosa ventilator-associated pneumonia: a competing risks approach to investigate the OUTCOMEREA database

Recommendations on infrastructure and organization of adult ICUs in resource-limited settings

Epigenome-wide association study for 28-day survival of acute respiratory distress syndrome

Correction to: Should all ICU clinicians regularly be tested for burnout? No

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Update AINS